|
TTF2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.82125492043906E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.13950026770749E-10 |
| Normal-vs-Stage2 |
1.64061999999854E-05 |
| Normal-vs-Stage3 |
1.75170000726865E-09 |
| Normal-vs-Stage4 |
3.97710000488161E-08 |
| Stage1-vs-Stage2 |
8.846400E-01 |
| Stage1-vs-Stage3 |
3.652000E-01 |
| Stage1-vs-Stage4 |
3.419400E-01 |
| Stage2-vs-Stage3 |
6.367200E-01 |
| Stage2-vs-Stage4 |
5.278000E-01 |
| Stage3-vs-Stage4 |
8.061600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.98170410373677E-11 |
| Normal-vs-AfricanAmerican |
1.562290E-04 |
| Normal-vs-Asian |
1.69544999999438E-05 |
| Caucasian-vs-AfricanAmerican |
6.929400E-01 |
| Caucasian-vs-Asian |
9.029000E-01 |
| AfricanAmerican-vs-Asian |
6.964200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.04559694236173E-11 |
| Normal-vs-Female |
4.59549953646388E-10 |
| Male-vs-Female |
7.691600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.99720000327153E-08 |
| Normal-vs-Age(41-60Yrs) |
9.46599465478926E-11 |
| Normal-vs-Age(61-80Yrs) |
7.82380005226457E-09 |
| Normal-vs-Age(81-100Yrs) |
5.899300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.353600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.032600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.543200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.676400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.346000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.830000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.886000E-01 |
| Classical-VS-Follicular |
3.396000E-03 |
| Classical-VS-Other |
3.755800E-01 |
| Classical-VS-Normal |
3.48170003938719E-09 |
| Tall-VS-Follicular |
2.190600E-01 |
| Tall-VS-Other |
5.253400E-01 |
| Tall-VS-Normal |
4.4076000000004E-05 |
| Follicular-VS-Other |
9.212800E-01 |
| Follicular-VS-Normal |
2.41510034193482E-10 |
| Other-VS-Normal |
5.579400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.21409557354946E-11 |
| Normal-vs-N1 |
5.15280000001894E-07 |
| N0-vs-N1 |
9.750400E-01 |
|
|
